
China’s largest pharmaceutical company launches public offering on the Hong Kong stock exchange
Hengrui, a pharmaceutical company based in Jiangsu province, China, has announced plans to raise funds through the sale of 224.5 million shares on the Hong Kong stock exchange. The offering could generate up to 9.89 billion Hong Kong dollars (€1.13 billion …